Astec LifeScences submits postal ballot notice ads

0 min read     Updated on 04 Jun 2026, 02:56 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Astec LifeScences Limited submitted copies of newspaper advertisements to stock exchanges confirming the dispatch of its postal ballot notice dated 2 June 2026. The advertisements were published on 3 June 2026 in Business Standard and Mumbai Lakshadeep. The filing complies with SEBI regulations and was signed by the Company Secretary.

powered bylight_fuzz_icon
42013738

*this image is generated using AI for illustrative purposes only.

Astec LifeScences Limited submitted copies of newspaper advertisements to BSE Limited and National Stock Exchange of India Limited confirming the dispatch of its postal ballot notice. The notice, dated 2 June 2026, was dispatched to members, with advertisements published on 3 June 2026 in Business Standard (All Editions, English) and Mumbai Lakshadeep (Mumbai Edition, Marathi). The intimation was uploaded on the company’s website.

The submission complies with Regulations 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Tejashree Pradhan, Company Secretary & Compliance Officer, signed the filing on behalf of Astec LifeScences Limited.

Historical Stock Returns for Astec Lifesciences

1 Day5 Days1 Month6 Months1 Year5 Years
-2.48%-0.43%+6.37%-6.98%+4.98%-45.37%

What specific resolutions are proposed in the postal ballot notice?

What is the expected timeline for the postal ballot results to be declared?

How might the outcomes of the postal ballot impact Astec LifeSciences' strategic direction?

Astec LifeSciences seeks ₹405 crore related party transactions approval

2 min read     Updated on 03 Jun 2026, 04:22 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Astec LifeSciences Limited has announced a postal ballot to seek shareholder approval for related party transactions totaling ₹405 crore with Godrej Agrovet Limited and Godrej Industries Limited for FY27. The ballot also includes resolutions to appoint Mr. Arijit Mukherjee as Executive Director and appoint other directors to the Board. E-voting is scheduled from June 5 to July 4, 2026.

powered bylight_fuzz_icon
42029562

*this image is generated using AI for illustrative purposes only.

Astec LifeSciences Limited has initiated a postal ballot process to seek shareholder approval for related party transactions with its holding companies, Godrej Agrovet Limited and Godrej Industries Limited, for the financial year 2026-27. The company proposes to enter into transactions worth an aggregate of ₹405 crore, subject to arm’s length pricing and ordinary course of business conditions. The resolutions also include the appointment of Mr. Arijit Mukherjee as Executive Director and the elevation of Mr. Vishal Sharma and Mr. Burjis N. Godrej to the Board.

The Board of Directors, based on the recommendation of the Audit Committee, has identified that the proposed transactions exceed the materiality threshold defined under Regulation 23(4) of the SEBI Listing Regulations. Consequently, shareholder approval is required to ratify these arrangements. The company stated that these transactions are expected to enhance capacity utilisation and improve operational efficiency by leveraging group synergies.

Related Party Transactions

The company has proposed an aggregate limit of ₹300 crore for transactions with Godrej Agrovet Limited, its holding company, and ₹105 crore for transactions with Godrej Industries Limited, its ultimate holding company. These limits cover the sale and purchase of goods, services, and inter-corporate deposits. The transactions will be valid for the financial year 2026-27.

Related Party Transaction Limit (₹) Nature of Transactions
Godrej Agrovet Limited 300 Crore Sale/Purchase of goods, services, Inter-corporate deposits
Godrej Industries Limited 105 Crore Sale/Purchase of goods, services, Rent, Reimbursement

The company’s consolidated turnover for the financial year 2025-26 was ₹45,321.65 lakh. The proposed limits represent 66.19% and 23.17% of the annual consolidated turnover for transactions with Godrej Agrovet Limited and Godrej Industries Limited, respectively.

Director Appointments

Shareholders are also asked to approve the appointment of Mr. Arijit Mukherjee as an Executive Director for a term of three years from April 13, 2026, to April 12, 2029. His remuneration package includes a basic salary range of ₹35 lakh to ₹42 lakh per annum, allowances and perquisites ranging from ₹1.18 crore to ₹1.40 crore, and a performance-linked variable remuneration of up to ₹36 lakh. Additionally, the appointment of Mr. Vishal Sharma and Mr. Burjis N. Godrej as Non-Executive, Non-Independent Directors, and Mr. Mathew Eipe as an Independent Director, are up for approval.

Voting Process

The e-voting facility will be available from 9.00 a.m. (IST) on June 5, 2026, until 5.00 p.m. (IST) on July 4, 2026. Members holding shares as of the cut-off date, May 29, 2026, are eligible to vote. The results of the postal ballot will be declared within two working days from the close of voting. Mr. Vikas R. Chomal, Practicing Company Secretary, has been appointed as the Scrutinizer for the process.

Historical Stock Returns for Astec Lifesciences

1 Day5 Days1 Month6 Months1 Year5 Years
-2.48%-0.43%+6.37%-6.98%+4.98%-45.37%

How will the high dependency on related party transactions, accounting for nearly 90% of the proposed limits against annual turnover, impact Astec LifeSciences' operational autonomy and market perception?

What specific strategic synergies does the company plan to leverage with Godrej Agrovet and Godrej Industries to ensure the projected enhancement in capacity utilisation and operational efficiency?

Will the significant capital allocation towards inter-corporate deposits with holding companies constrain Astec LifeSciences' ability to fund independent R&D or capital expenditure initiatives?

More News on Astec Lifesciences

1 Year Returns:+4.98%